Skip to content
The Department of Neurology has a long and dynamic legacy of promoting diversity and inclusion in the workplace and health care setting.
Contact our scheduling team to make an in-person or Virtual Visit appointment
Learn about our Adult Neurology and Child Neurology Residency Programs.
Clinical trials are a key component of the research mission of the Department of Neurology at CUIMC
Showing 71 - 80 of 125 results.
Decades before the first symptoms of Alzheimer’s appear, the brain’s neurons start secreting tau proteins, one of the first changes known to occur in the course of the disease.
Philip De Jager, a neurologist at Columbia University in New York, investigated what epigenetic changes occurred in the presence of tau tangles.
Two preliminary studies offer mixed news for heart patients who fall ill with COVID-19.
Heart attack risk increases quickly after a flu-like illness, while stroke risk rises slower, according to new research.
In recognition of Hispanic Heritage Month, CUIMC News will feature profiles of faculty members who are helping the medical center achieve excellence in research, education, and patient care.
When COVID-19 patients started inundating New York City hospitals in March, Columbia neurologists were ready, thanks to some advanced preparation.
“Anything that can slow down the rate of decline in a disease that has no cure—or no treatment to reverse symptoms—is good,” said Jinsy Andrews.
“This is very encouraging,” said Dr. Neil Shneider, director of the Eleanor and Lou Gehrig A.L.S. Center at Columbia University, who was not involved.
In the nine months since the coronavirus emerged, the global medical community has learned about how to detect the virus, restrict its spread and better treat patients.
A Harris poll on behalf of the American Heart Association found roughly 1 in 4 adults experiencing a heart attack or stroke would rather stay at home than risk getting infected with COVID-19.